Perioperative Anaphylaxis

446
Mertes et al
REFERENCES
1. Lienhart A, Auroy Y, Pequignot F, et al. Survey of anesthesia-related mortality in
France. Anesthesiology 2006;105(6):1087–97.
2. Mertes PM, Laxenaire MC, Lienhart A, et al. Reducing the risk of anaphylaxis
during anaesthesia: guidelines for clinical practice. J Investig Allergol Clin Immunol
2005;15(2):91–101.
3. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for
global use: report of the Nomenclature Review Committee of the World Allergy
Organization, 2003. J Allergy Clin Immunol 2004;113(5):832–6.
4. Laxenaire MC. [What is the real risk of drug hypersensitivity in anesthesia? Incidence.
Clinical aspects. Morbidity-mortality. Substances responsible]. Ann Fr
Anesth Reanim 2002;21(Suppl 1):38s–54s [in French].
5. Fisher MM, More DG. The epidemiology and clinical features of anaphylactic
reactions in anaesthesia. Anaesth Intensive Care 1981;9(3):226–34.
6. Mertes PM, Laxenaire MC. Allergic reactions occurring during anaesthesia. Eur J
Anaesthesiol 2002;19:240–62.
7. Watkins J. Adverse anaesthetic reactions: an update from a proposed national
reporting and advisory service. Anaesthesia 1985;40(8):797–800.
8. Thienthong S, Hintong T, Pulnitiporn A. The Thai Anesthesia Incidents Study
(THAI Study) of perioperative allergic reactions. J Med Assoc Thai 2005;
88(Suppl 7):S128–33.
9. Whittington T, Fisher MM. Anaphylactic and anaphylactoid reactions: clinical
anaesthesiology. Baillieres Clin Anaesthesiol 1998;12:301–23.
10. Laxenaire MC. Epidemiologie des reactions anaphylactoïdes peranesthesiques.
Quatrième enquête multicentrique (juillet 1994–decembre 1996). Ann Fr Anesth
Reanim 1999;18:796–809 [in French].
11. Escolano F, Valero A, Huguet J, et al. [Prospective epidemiologic study of perioperative
anaphylactoid reactions occurring in Catalonia (1996–7)]. Rev Esp
Anestesiol Reanim 2002;49(6):286–93 [in Spanish].
12. Harboe T, Guttormsen AB, Irgens A, et al. Anaphylaxis during anesthesia in
Norway: a 6-year single-center follow-up study. Anesthesiology 2005;102(5):
897–903.
13. Fisher M, Baldo BA. Anaphylaxis during anaesthesia: current aspects of diagnosis
and prevention. Eur J Anaesthesiol 1994;11(4):263–84.
14. Laxenaire M, Mertes PM, GERAP. Anaphylaxis during anaesthesia: results of
a 2 year survey in France. Br J Anaesth 2001;21(1):549–58.
15. Mertes PM, Alla F, Laxenaire MC. Anaphylactic and anaphylactoid reactions occurring
during anesthesia in France in 1999–2000. Anesthesiology 2003;99:536–45.
16. Mertes PM, Laxenaire MC. [Anaphylactic and anaphylactoid reactions occurring
during anaesthesia in France: seventh epidemiologic survey (January 2001–
December 2002)]. Ann Fr Anesth Reanim 2004;23(12):1133–43 [in French].
17. Mitsuhata H, Matsumoto S, Hasegawa J. [The epidemiology and clinical
features of anaphylactic and anaphylactoid reactions in the perioperative period
in Japan]. Masui 1992;41:1664–9 [in Japanese].
18. Light KP, Lovell AT, Butt H, et al. Adverse effects of neuromuscular blocking
agents based on yellow card reporting in the UK: are there differences between
males and females? Pharmacoepidemiol Drug Saf 2006;15(3):151–60.
19. Baldo B, Fisher M, Pham N. On the origin and specificity of antibodies to neuromuscular
blocking (muscle relaxant) drugs. An immunochemical perspective.
Clin Exp Allergy 2009;39(3):325–44.